News
ABT
115.29
+2.74%
3.08
Weekly Report: what happened at ABT last week (0216-0220)?
Weekly Report · 16h ago
Best Dividend Kings: February 2026
Seeking Alpha · 22h ago
Abbott Laboratories Streamlines Governance With Smaller Board
TipRanks · 3d ago
Exact Sciences Stockholders Voted To Approve Proposed Acquisition By Abbott
Benzinga · 3d ago
Abbott Laboratories declares $0.63 dividend
Seeking Alpha · 3d ago
BTIG Sticks to Their Buy Rating for Abbott Laboratories (ABT)
TipRanks · 3d ago
Press Release: Abbott declares 409th consecutive quarterly dividend
Dow Jones · 3d ago
Abbott declares 409th consecutive quarterly dividend
Barchart · 3d ago
China drug licensing deals surge nearly 10-fold in value since 2021
Seeking Alpha · 4d ago
ABT April 17th Options Begin Trading
NASDAQ · 4d ago
NIH director reportedly being tapped as acting CDC director
Seeking Alpha · 5d ago
Notable ETF Outflow Detected - XLV, ABT, PFE, DHR
NASDAQ · 5d ago
IXJ: Healthcare Sector Dashboard For February
Seeking Alpha · 5d ago
RFK Jr.'s Next Overhaul: America's Baby Formula Guidelines
The Wall Street Journal · 6d ago
A Look At Abbott Laboratories (ABT) Valuation As Libre 3 Lawsuit Raises Product Safety Concerns
Simply Wall St · 02/16 18:19
Weekly Report: what happened at ABT last week (0209-0213)?
Weekly Report · 02/16 09:14
Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells
Seeking Alpha · 02/15 23:08
Kraft Heinz: Looks Like Berkshire Got Its Wish (Rating Downgrade)
Seeking Alpha · 02/14 12:30
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and Abbott Laboratories (ABT)
TipRanks · 02/13 20:20
Should FreeStyle Libre 3 Safety Lawsuit and Dividend Hike Require Action From Abbott (ABT) Investors?
Simply Wall St · 02/13 17:41
More
Webull provides a variety of real-time ABT stock news. You can receive the latest news about Abbott Labs through multiple platforms. This information may help you make smarter investment decisions.
About ABT
Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.